Clinical Characteristics of Patients with HNF1-alpha MODY: A Literature Review and Retrospective Chart Review

Qinying Zhao,Li Ding,Jinhong Sun,Min Wang,Xin Li,Ming Liu,YIng Yang
DOI: https://doi.org/10.3389/fendo.2022.900489
IF: 6.055
2022-06-20
Frontiers in Endocrinology
Abstract:The clinical manifestation of hepatocyte nuclear factor-1-alpha ( HNF1-alpha ) maturity-onset diabetes of the young (MODY) is highly variable. This study aims to investigate the clinical characteristics of patients with HNF1-alpha MODY in general, by geographical regions (Asian or non-Asian), HNF1-alpha mutations, and islet autoantibody status. A literature review and a chart review of patients with HNF1-alpha MODY were performed. The means and proportions from studies were pooled using the inverse variance method for pooling, and subgroup analyses were performed. A total of 109 studies involving 1,325 patients [41.5%, 95% confidence interval (CI): 35.2, 48.1; male] were identified. The mean age of diagnosis was 20.3 years (95% CI: 18.3–22.2), and the mean glycated hemoglobin was 7.3% (95% CI: 7.2–7.5). In comparison, Asian patients exhibited significantly higher HbA1c ( p = 0.007) and 2-h post-load C-peptide ( p = 0.012) levels and lower levels of triglyceride (TG) ( p < 0.001), total cholesterol (TC) ( p < 0.001), and high-density lipoprotein cholesterol (HDL-c) ( p < 0.001) and less often had macrovascular complications ( p = 0.014). The age of diagnosis was oldest in patients with mutations in the transactivation domain ( p < 0.001). The levels of 2-h post-load C-peptide ( p < 0.001), TG ( p = 0.007), TC ( p = 0.017), and HDL-c ( p = 0.001) were highest and the prevalence of diabetic neuropathy was lowest ( p = 0.024) in patients with DNA-binding domain mutations. The fasting ( p = 0.004) and 2-h post-load glucose ( p = 0.003) levels and the prevalence of diabetic neuropathy ( p = 0.010) were higher among patients with positive islet autoantibodies. The study demonstrated that the clinical manifestations of HNF1-alpha MODY differed by geographical regions, HNF1-alpha mutations, and islet autoantibody status.
endocrinology & metabolism
What problem does this paper attempt to address?